Dr. Reddy's Laboratories Limited has informed the Exchange about Board meeting intimation for recommending final dividend, if any, for Financial Year 2025-26

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.8%1-day move

₹1221.50

prior close

₹1215.20

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.4+0.3+0.3+0.0+0.8-0.0-0.3+8.5+7.5+10.3+5.0+8.9+3.9-1.0

Up moveDown movePending

AI summary

Dr. Reddy's Laboratories has informed exchanges that its Board of Directors will meet to consider recommending the final dividend for Financial Year 2025-26. This is a standard intimation under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29). The filing, dated April 16, 2026, references an earlier intimation from March 23, 2026. No specific dividend amount or percentage is disclosed in this notice — the board will consider the proposal 'if any.' The stock is listed on NSE (DRREDDY), BSE (500124), and NYSE (RDY).

Likely market impact

This is a routine pre-meeting intimation with no immediate share price impact. The actual dividend quantum and record date will be announced after the board meeting, which shareholders should monitor for income expectations.